Chinese herbal medicines for mild cognitive impairment: A protocol for meta-analysis and trial sequential analysis

BACKGROUND: Mild cognitive impairment (MCI), as a common neurodegenerative aging disease representing an intermediate stage between normal cognitive functioning and dementia, poses an excessive burden on health care. The clinical benefit of Chinese herbal medicines (CHMs) for MCI remains inconclusiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Si-Chun, Zhang, Li-Min, Wang, Chun-Xu, Qu, Yan-Jie, Ma, Jing-Yi, Zhen, Rong-Rong, Gu, Chao, Yuan, Can-Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483849/
https://www.ncbi.nlm.nih.gov/pubmed/34596133
http://dx.doi.org/10.1097/MD.0000000000027323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483849/
https://www.ncbi.nlm.nih.gov/pubmed/34596133
http://dx.doi.org/10.1097/MD.0000000000027323

Ejemplares similares